07971459383

Change Language

KETHAN PHARMA DISTRIBUTORS
GST : 36ABMPO2384G1ZD

Our Products

Pharmaceutical Tablets

Pharmaceutical Injection

Pharmaceutical Capsules

Anti Cancer Injection

Mircera 50 Mcg Injection

Therapy Lotion

Cardiovascular Injection

Recombinant Tissue Plasminogen Activator For Injection 20 Mg Kit

Pharmaceutical Cream

Mouth Freshener Spray

X-Wet Saliva Supplement Mouth Spray

Oral Suspension

Megestrol Acetate Oral Suspension USP

Pharmaceutical Syrup

Curcuage Liquid

Bortezomib Injection IP 2 Mg

Name: Bortezomib Injection IP 2 Mg
Brand: KETHAN PHARMA DISTRIBUTORS
Price: 1500 INR
Availability: InStock

Price 1500 INR/ Unit

Get a Price/Quote

MOQ : 1 Unit

Bortezomib Injection IP 2 Mg Specification

Dosage Form
Lyophilized powder

Brand Name
Borviz

Salt Composition
Bortezomib

Packaging Type
Box

Origin of Medicine
India

Life Span
Long shelf life

Pacakaging (Quantity Per Box)
2 mg/vial

Drug Type
Injection

Ingredients
Bortezomib

Physical Form
Injection

Function
Anti Cancer

Recommended For
Cancer treatment

Dosage
2 mg

Quantity
1 vial per box

Storage Instructions
Store below 25C

Usage
Hospital

Bortezomib Injection IP 2 Mg Trade Information

Minimum Order Quantity
1 Unit

Payment Terms
Cash in Advance (CID)

Supply Ability
1000 Units Per Month

Delivery Time
7 Days

Main Domestic Market
All India

About Bortezomib Injection IP 2 Mg

Spotlight your hospital's oncology care with Borviz Bortezomib Injection IP 2 Mg-an anti-cancer solution made in India. Transform cancer treatment protocols with this lyophilized powder, ensuring a radiant impact on patient outcomes. Packaged as a single vial per box, Borviz delivers an unprecedented standard and long shelf life. Shop now for the lowest price available from leading exporters, suppliers, and traders. With its spectacular efficacy and trusted Indian origin, this injection stands as the preferred choice for hospitals seeking reliability and therapeutic excellence.

Bortezomib Injection Applications and Medical Surfaces

Bortezomib Injection IP 2 Mg is specifically formulated for hospital usage, exemplifying safe and efficient drug delivery on professional medical surfaces. It is indicated primarily in the area of cancer treatment, administered under healthcare supervision. The injection's distinct application surfaces include clinical infusion areas, specialized oncology departments, and inpatient care units. Its targeted function as an anticancer agent ensures efficacy in complex and demanding therapeutic landscapes, establishing Borviz as an integral part of advanced hospital pharmacy inventories.

Packaging, Freight, and Certifications for Bortezomib Injection

Borviz Bortezomib Injection IP 2 Mg is supplied in robust box packaging-1 vial per box, with each vial containing 2 mg of lyophilized powder. All stock is ready for prompt freight dispatch, ensuring minimal lead time and rapid hospital supply. List price options and flexible sample availability facilitate convenient procurement. The product carries essential certifications and adheres to international standards, positioning it as a reliable solution for oncology needs in both domestic and export markets.

FAQ's of Bortezomib Injection IP 2 Mg:

Q: How is Bortezomib Injection IP 2 Mg typically used in a hospital setting?

A: It is administered by healthcare professionals in hospital environments, mainly within oncology departments, as part of cancer treatment protocols.

Q: What is the main benefit of using Borviz Bortezomib Injection for cancer treatment?

A: Borviz offers targeted anticancer action, supported by high efficacy and a convenient dosage form, helping improve patient outcomes in oncology care.